Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:0
作者
Haşim Boyacı
Hale Maral
Gupse Turan
İlknur Başyiğit
Meltem Ö. Dillioğlugil
Füsun Yıldız
Melih Tugay
Ayşe Pala
Cengiz Erçin
机构
[1] Kocaeli University School of Medicine,Department of Chest Diseases
[2] Kocaeli University School of Medicine,Department of Biochemistry
[3] Kocaeli University School of Medicine,Department of Pathology
[4] Kocaeli University School of Medicine,Department of Pediatric Surgery
[5] Kocaeli TIP Fakültesi,undefined
来源
Molecular and Cellular Biochemistry | 2006年 / 281卷
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
暂无
中图分类号
学科分类号
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague–Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin + erdosteine (BLM + ERD), and saline alone (control). The BLM and BLM + ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM + ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM + ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 ± 0.15, 0.11 ± 0.02, and 0.087± 0.03 nmol/mg protein in BLM, BLM + ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 ± 0.06, 0.60 ± 0.09, and 0.56± 0.1 μmol/mg protein in BLM, BLM + ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 ± 12.4, 253.2± 25.2, and 287.9± 34.4 nmol/mg protein) (SOD levels were 1.42± 0.12, 1.75± 0.17, and 1.89± 0.09 U/mg protein) in BLM, BLM + ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:8
相关论文
共 50 条
[31]   The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats [J].
Arslan, SO ;
Zerin, M ;
Vural, H ;
Coskun, A .
JOURNAL OF PINEAL RESEARCH, 2002, 32 (01) :21-25
[32]   Plumbagin attenuates Bleomycin-induced lung fibrosis in mice [J].
Saber Mehdizadeh ;
Marjan Taherian ;
Paria Bayati ;
Kazem Mousavizadeh ;
Salar Pashangzadeh ;
Ali Anisian ;
Nazanin Mojtabavi .
Allergy, Asthma & Clinical Immunology, 18
[33]   Zingerone Attenuates bleomycin-Induced Pulmonary Fibrosis in Rats [J].
Mansouri, Mohammad Taghi ;
Vardanjani, Hossein Rajabi ;
Hemmati, Ali Asghar ;
Tabandeh, Mohammad Reza ;
Rezaie, Anahita ;
Pashmforosh, Marzie ;
Angali, Kambiz Ahmadi .
JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2019, 14 (01)
[34]   Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats [J].
Gong, LK ;
Li, XH ;
Wang, H ;
Zhang, L ;
Chen, FP ;
Cai, Y ;
Qi, XM ;
Liu, LL ;
Liu, YZ ;
Wu, XF ;
Huang, CG ;
Ren, J .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 96 (03) :537-544
[35]   Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats [J].
Wan, Yun-Yan ;
Tian, Guang-Yan ;
Guo, Hai-Sheng ;
Kang, Yan-Meng ;
Yao, Zhou-Hong ;
Li, Xi-Li ;
Liu, Qing-Hua ;
Lin, Dian-Jie .
RESPIRATORY RESEARCH, 2013, 14
[36]   Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats [J].
Wang, HD ;
Yamaya, M ;
Okinaga, S ;
Jia, YX ;
Kamanaka, M ;
Takahashi, H ;
Guo, LY ;
Ohrui, T ;
Sasaki, H .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (03) :406-411
[37]   Feitai attenuates bleomycin-induced pulmonary fibrosis in rats [J].
Gong, LK ;
Li, XH ;
Wang, H ;
Zhang, L ;
Cai, Y ;
Qi, XM ;
Liu, LL ;
Liu, YZ ;
Wu, XF ;
Chen, FP ;
Huang, CG ;
Ren, J .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (05) :634-640
[38]   Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis [J].
Fridlender, Z. G. ;
Cohen, P. Y. ;
Golan, O. ;
Arish, N. ;
Wallach-Dayan, S. ;
Breuer, R. .
EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (02) :205-213
[39]   Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches [J].
Mohammed, Shaimaa M. ;
Al-Saedi, Haider Falih Shamikh ;
Mohammed, Amjed Qasim ;
Amir, Ahmed Ali ;
Radi, Usama Kadem ;
Sattar, Ruaa ;
Ahmad, Irfan ;
Ramadan, Montather F. ;
Alshahrani, Mohammad Y. ;
Balasim, Halah Majeed ;
Alawadi, Ahmed .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (03) :1845-1870
[40]   Antifibrosis effects of Shenge Yangfei Capsules on bleomycin-induced pulmonary fibrosis in rats [J].
Hui Jia ;
Zuojun Wang ;
Qiong Wu ;
Ziru Xu ;
Jingyi Zhang ;
Hongda Ma ;
Qingchun Zhao .
Chinese Herbal Medicines, 2018, (04) :411-415